Does the craniofacial fibro-osseosus lesions and its treatment affect the quality of life of afflicted individuals?
Ekene Polycarp Onyebuchi1, Benjamin Fomete2, Rowland Agbara3
1 International Institute for Dental and Craniofacial Research, Department of Oral and Maxillofacial Surgery, David Umahi Federal University of Health Sciences, Uburu.
2 Department of Oral and Maxillofacial Surgery, Ahmadu Bello University / Ahmadu Bello University Teaching Hospital, Zaria.
3 Department of Oral and Maxillofacial Surgery, University of Jos / Jos University Teaching Hospital, Jos.
DOI: 10.54936/haoms263147156
SUMMARY: Background: Quality of life assessment is an often overlooked aspect of patient care since much emphasis placed on cure by managing surgeons. This study assessed the quality of life of individuals with craniofacial fibro-osseous lesions.
Materials and methods: the study involves individuals with fibro-osseous lesions of the craniofacial region who presented at the Ahmadu Bello University Teaching Hospital, Zaria from September, 2016 to December, 2017. The OHIP-14 and a modified version 4 of the UW-QoL questionnaires were utilized, and were administered at presentation and six months after treatment.
Results: 50 cases of CFOL were reported with mean QoL scores of 82.2 ± 9.5 (UW-QoLv4) and 9.2 ± 4.8 (OHIP-14) at presentation. The appearance (UW-QoLv4) and the self-consciousness (OHIP-14) domains had the worst ratings, and subjects on observation had a better mean QoL score (86.3 ± 8.1) (UW-QoLv4), (6.5 ± 0.7) (OHIP-14) than those who later had surgery (82 ± 9.6) (UW-QoLv4), (9.3 ± 4.8), (OHIP-14), (UW-QoLv4), (OHIP-14). Six months post-treatment, the mean QoL scores were 91.6 ± 4.8 (UW-QoLv4) and 5.9 ± 3.6 (OHIP-14). The mean QoL score of subjects under observation (88.8 ± 8.1) was less than that of those who had surgery (91.8 ± 8.5) for UW-QoLv4. Similarly, the OHIP-14 form recorded a higher mean QoL score for subjects under observation (6.5 ± 4.9) than those who had surgery (5.9 ± 3.6).
Conclusion: Radical surgeries without rehabilitation greatly impact the QoL of affected subjects.
KEY WORDS: craniofacial, fibro-osseous, quality of life, UW-QoLv4, OHIP-14.
REFERENCES
1. The WHOQOL Group. The development of the World Health Organization quality of life assessment instrument (The WHOQoL). In: Orley J, Kuyken W, Editors. Quality of Life Assessment: international perspectives. Heidelberg: Springer-Verlag; 1994. Pp 41-57.
2. Larson JE. “The conceptualization of health”. Med Care Res and Rev. 1999; 56: 123-136.
3. Greenfield S, Nelson EC. Recent developments and future issues in the use of health status assessment measures in clinical setting. Med Care. 1992; 30: 23-41.
4. Guyatt G, Freenz D, Patrick D. Measuring health-related quality of life. Ann Intern Med. 1993; 118: 622-629.
5. McGrath C, Bedi R. “The importance of oral health to older people’s quality of life” Gerodontology. 1999; 16: 59-63.
6. Waldron C. Fibro-osseous lesions of the jaws. J Oral Maxillofacial Surg. 1985; 43: 249-262.
7. Brannon RB, Fowler CB. Benign fibro-osseous lesions: a review of current concepts. Adv Anat Pathol.2001; 8:126-143.
8. Jundt G. Fibrous dysplasia. In Barnes L, Everson JW, Reichart P, Sidransky D, (editors). World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Lyon: International Agency for Research on Cancer (IARC); 2005. Pp. 321-322
9. Rajpal K, Argarwal R, Chabra R, Bhattacharya M. Updated classification schemes for fibro-osseous lesions of the oral and maxillofacial region: a review. J Dent Med Sci. 2014;13:99-103.
10. Speight PM, Carlos R. Maxillofacial fibro-osseous lesions. Mini symposium: Head and Neck Pathology. Curr Diag Pathol. 2006; 12:1-10.
11. Slootweg PJ. Maxillofacial fibro-osseous lesions: classification and differential diagnosis. Semin Diagn Pathol. 1996; 13:104-112.
12. Slade GD, Spencer AJ. Derivation and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994; 11:3-11.
13. Eversole R, Su L, El-Mofty S. Benign fibro-osseous lesions of the craniofacial complex: a review. Head and Neck Pathol. 2008; 2: 177-202.
14. Muwazi LM, Kamulegeya A. Maxillofacial fibro-osseous lesions in Uganda. Oral Dis. 2015; 21:79-85.
15. Valentini V, Casonni A, Marianetti TM, Terenzi V, Fadda MT, Ianetti G. Cranimaxillofacial fibrous dysplasia: conservative management or radical surgery? A retrospective study of 68 patients. Plast Reconstr Surg. 2009; 123:653-660.
16. Menon S, Venkatswamy S, Ramu V, Banu K, Ehtaih S, Kashyap VM. Craniofacial fibrous dysplasia: surgery and literature review. Ann Maxillofac Surg. 2013;3 :66-71.
17. Li X, Zhu K, Liu F, Li H. Assessment of the quality of life in giant ameloblastoma adolescent patients who have had mandible defects reconstructed with free fibula flap. World J Surg Oncol. 2014; 12: 201-206.
18. Barrios R, Bravo M, Gil-Montoya JA, Martinez-Lara I, Garcia-Medina B, Tsakos G. Oral and general health related quality of life in patients treated for oral cancer compared to control group. Health Qual Life Outcomes. 2015; 13: 1-8.
19. Silva CAB, Grando LJ, Fabro SML, Ferreira de Mello ALS. Oral health related quality of life in patients with stomatological diseases. Baltic Dent Maxillofac J. 2015; 17: 48-53.
20. Majoor BSJ, Andela CD, Bruggemann J, Van de Sande MAJ, Kaptein AdA, Hamdy NAT, et al. Determinants of impaired quality of life in patients with fibrous dysplasia. Orphanet J Rare Dis. 2017; 12(1):80-88.
1 International Institute for Dental and Craniofacial Research, Department of Oral and Maxillofacial Surgery, David Umahi Federal University of Health Sciences, Uburu.
2 Department of Oral and Maxillofacial Surgery, Ahmadu Bello University / Ahmadu Bello University Teaching Hospital, Zaria.
3 Department of Oral and Maxillofacial Surgery, University of Jos / Jos University Teaching Hospital, Jos.
DOI: 10.54936/haoms263147156
SUMMARY: Background: Quality of life assessment is an often overlooked aspect of patient care since much emphasis placed on cure by managing surgeons. This study assessed the quality of life of individuals with craniofacial fibro-osseous lesions.
Materials and methods: the study involves individuals with fibro-osseous lesions of the craniofacial region who presented at the Ahmadu Bello University Teaching Hospital, Zaria from September, 2016 to December, 2017. The OHIP-14 and a modified version 4 of the UW-QoL questionnaires were utilized, and were administered at presentation and six months after treatment.
Results: 50 cases of CFOL were reported with mean QoL scores of 82.2 ± 9.5 (UW-QoLv4) and 9.2 ± 4.8 (OHIP-14) at presentation. The appearance (UW-QoLv4) and the self-consciousness (OHIP-14) domains had the worst ratings, and subjects on observation had a better mean QoL score (86.3 ± 8.1) (UW-QoLv4), (6.5 ± 0.7) (OHIP-14) than those who later had surgery (82 ± 9.6) (UW-QoLv4), (9.3 ± 4.8), (OHIP-14), (UW-QoLv4), (OHIP-14). Six months post-treatment, the mean QoL scores were 91.6 ± 4.8 (UW-QoLv4) and 5.9 ± 3.6 (OHIP-14). The mean QoL score of subjects under observation (88.8 ± 8.1) was less than that of those who had surgery (91.8 ± 8.5) for UW-QoLv4. Similarly, the OHIP-14 form recorded a higher mean QoL score for subjects under observation (6.5 ± 4.9) than those who had surgery (5.9 ± 3.6).
Conclusion: Radical surgeries without rehabilitation greatly impact the QoL of affected subjects.
KEY WORDS: craniofacial, fibro-osseous, quality of life, UW-QoLv4, OHIP-14.
REFERENCES
1. The WHOQOL Group. The development of the World Health Organization quality of life assessment instrument (The WHOQoL). In: Orley J, Kuyken W, Editors. Quality of Life Assessment: international perspectives. Heidelberg: Springer-Verlag; 1994. Pp 41-57.
2. Larson JE. “The conceptualization of health”. Med Care Res and Rev. 1999; 56: 123-136.
3. Greenfield S, Nelson EC. Recent developments and future issues in the use of health status assessment measures in clinical setting. Med Care. 1992; 30: 23-41.
4. Guyatt G, Freenz D, Patrick D. Measuring health-related quality of life. Ann Intern Med. 1993; 118: 622-629.
5. McGrath C, Bedi R. “The importance of oral health to older people’s quality of life” Gerodontology. 1999; 16: 59-63.
6. Waldron C. Fibro-osseous lesions of the jaws. J Oral Maxillofacial Surg. 1985; 43: 249-262.
7. Brannon RB, Fowler CB. Benign fibro-osseous lesions: a review of current concepts. Adv Anat Pathol.2001; 8:126-143.
8. Jundt G. Fibrous dysplasia. In Barnes L, Everson JW, Reichart P, Sidransky D, (editors). World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Lyon: International Agency for Research on Cancer (IARC); 2005. Pp. 321-322
9. Rajpal K, Argarwal R, Chabra R, Bhattacharya M. Updated classification schemes for fibro-osseous lesions of the oral and maxillofacial region: a review. J Dent Med Sci. 2014;13:99-103.
10. Speight PM, Carlos R. Maxillofacial fibro-osseous lesions. Mini symposium: Head and Neck Pathology. Curr Diag Pathol. 2006; 12:1-10.
11. Slootweg PJ. Maxillofacial fibro-osseous lesions: classification and differential diagnosis. Semin Diagn Pathol. 1996; 13:104-112.
12. Slade GD, Spencer AJ. Derivation and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994; 11:3-11.
13. Eversole R, Su L, El-Mofty S. Benign fibro-osseous lesions of the craniofacial complex: a review. Head and Neck Pathol. 2008; 2: 177-202.
14. Muwazi LM, Kamulegeya A. Maxillofacial fibro-osseous lesions in Uganda. Oral Dis. 2015; 21:79-85.
15. Valentini V, Casonni A, Marianetti TM, Terenzi V, Fadda MT, Ianetti G. Cranimaxillofacial fibrous dysplasia: conservative management or radical surgery? A retrospective study of 68 patients. Plast Reconstr Surg. 2009; 123:653-660.
16. Menon S, Venkatswamy S, Ramu V, Banu K, Ehtaih S, Kashyap VM. Craniofacial fibrous dysplasia: surgery and literature review. Ann Maxillofac Surg. 2013;3 :66-71.
17. Li X, Zhu K, Liu F, Li H. Assessment of the quality of life in giant ameloblastoma adolescent patients who have had mandible defects reconstructed with free fibula flap. World J Surg Oncol. 2014; 12: 201-206.
18. Barrios R, Bravo M, Gil-Montoya JA, Martinez-Lara I, Garcia-Medina B, Tsakos G. Oral and general health related quality of life in patients treated for oral cancer compared to control group. Health Qual Life Outcomes. 2015; 13: 1-8.
19. Silva CAB, Grando LJ, Fabro SML, Ferreira de Mello ALS. Oral health related quality of life in patients with stomatological diseases. Baltic Dent Maxillofac J. 2015; 17: 48-53.
20. Majoor BSJ, Andela CD, Bruggemann J, Van de Sande MAJ, Kaptein AdA, Hamdy NAT, et al. Determinants of impaired quality of life in patients with fibrous dysplasia. Orphanet J Rare Dis. 2017; 12(1):80-88.
|
How to cite this article:
|
| ||
View the full-text PDF: